Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus

As many as 1 in 3 patients with gestational diabetes mellitus have impaired glucose metabolism when screened postpartum. These patients have a 40% to 70% lifetime risk of progression to type 2 diabetes mellitus, but progression can be delayed or prevented by lifestyle interventions or medication. Th...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2023-04, Vol.228 (4), p.B2-B9
Main Authors: Bauer, Samuel T., Cate, Jennifer J.M., Whitsel, Amy I., Combs, C. Andrew
Format: Article
Language:English
Subjects:
barriers
Blood Glucose - metabolism
cardiovascular disease
Diabetes Mellitus, Type 2 - diagnosis
Diabetes, Gestational - diagnosis
Female
fourth trimester
Glucose Tolerance Test
Humans
metabolic syndrome
obesity
Perinatology
Postpartum Period
Pregnancy
quality improvement
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913
cites cdi_FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913
container_end_page B9
container_issue 4
container_start_page B2
container_title American journal of obstetrics and gynecology
container_volume 228
creator Bauer, Samuel T.
Cate, Jennifer J.M.
Whitsel, Amy I.
Combs, C. Andrew
description As many as 1 in 3 patients with gestational diabetes mellitus have impaired glucose metabolism when screened postpartum. These patients have a 40% to 70% lifetime risk of progression to type 2 diabetes mellitus, but progression can be delayed or prevented by lifestyle interventions or medication. The American College of Obstetricians and Gynecologists and the American Diabetes Association recommend a glucose tolerance test at 4 to 12 weeks postpartum for all patients with gestational diabetes mellitus. Despite these recommendations, postpartum screening rates are typically
doi_str_mv 10.1016/j.ajog.2022.12.315
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2759962956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937822026011</els_id><sourcerecordid>2759962956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913</originalsourceid><addsrcrecordid>eNp9UU1vFCEYJsbGbqt_wIPh6GVGYBZmMF5MY9WkTdNsPRMWXrZsZmAEpk1_kX9TNlv15okAz9f7Pgi9paSlhIoP-1bv465lhLGWsraj_AVaUSL7RgxieIlWhBDWyK4fTtFZzvvDlUn2Cp12gg9rKegK_dpE46E8YRcTvtYFUtBjcwlFj_garDc-AN7MYHx92JQKmCCUj_h20aOvtAlK8gbHgMs94FT_cXR4jrnMOpVlwtbrLRTIOJsEEHzYYe2qDZ4T7IIO1T3jR1_u8Q5y1fexBvjHmmCsPkt-jU6cHjO8eT7P0Y_LL3cX35qrm6_fLz5fNabjojSOCEfX0NGeSGZsvzZgGeeWCcP41lnZsa2TljNOnO4NGRjtetvXdZgOQNLuHL0_6s4p_lxqIjX5bGoIHSAuWbGeSymY5KJC2RFqUsw5gVNz8pNOT4oSdShI7dWhIHUoSFGmakGV9O5Zf9lOYP9S_jRSAZ-OAKhTPnhIKtcVhTqHT2CKstH_T_83o_GlwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2759962956</pqid></control><display><type>article</type><title>Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus</title><source>Elsevier</source><creator>Bauer, Samuel T. ; Cate, Jennifer J.M. ; Whitsel, Amy I. ; Combs, C. Andrew</creator><creatorcontrib>Bauer, Samuel T. ; Cate, Jennifer J.M. ; Whitsel, Amy I. ; Combs, C. Andrew ; Society for Maternal-Fetal Medicine (SMFM) ; Patient Safety and Quality Committee ; Patient Safety and Quality Committee. Electronic address: smfm@smfm.org</creatorcontrib><description>As many as 1 in 3 patients with gestational diabetes mellitus have impaired glucose metabolism when screened postpartum. These patients have a 40% to 70% lifetime risk of progression to type 2 diabetes mellitus, but progression can be delayed or prevented by lifestyle interventions or medication. The American College of Obstetricians and Gynecologists and the American Diabetes Association recommend a glucose tolerance test at 4 to 12 weeks postpartum for all patients with gestational diabetes mellitus. Despite these recommendations, postpartum screening rates are typically &lt;50%, representing a major healthcare “quality gap.” The Society for Maternal-Fetal Medicine proposes a uniform metric that identifies the percentage of persons with gestational diabetes mellitus who completed a 75-g, 2-hour glucose tolerance test within 12 weeks after delivery. The metric is designed to be measured using diagnosis and procedure codes in payor claims data. Barriers to screening are discussed. Possible uses of the metric for quality improvement projects are outlined. Increasing the rate of postpartum diabetes screening should facilitate timely referral to implement lifestyle modifications, medication, and long-term follow-up. Use of the metric in financial incentive programs is discouraged at this time.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2022.12.315</identifier><identifier>PMID: 36584961</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>barriers ; Blood Glucose - metabolism ; cardiovascular disease ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes, Gestational - diagnosis ; Female ; fourth trimester ; Glucose Tolerance Test ; Humans ; metabolic syndrome ; obesity ; Perinatology ; Postpartum Period ; Pregnancy ; quality improvement</subject><ispartof>American journal of obstetrics and gynecology, 2023-04, Vol.228 (4), p.B2-B9</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913</citedby><cites>FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36584961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bauer, Samuel T.</creatorcontrib><creatorcontrib>Cate, Jennifer J.M.</creatorcontrib><creatorcontrib>Whitsel, Amy I.</creatorcontrib><creatorcontrib>Combs, C. Andrew</creatorcontrib><creatorcontrib>Society for Maternal-Fetal Medicine (SMFM)</creatorcontrib><creatorcontrib>Patient Safety and Quality Committee</creatorcontrib><creatorcontrib>Patient Safety and Quality Committee. Electronic address: smfm@smfm.org</creatorcontrib><title>Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>As many as 1 in 3 patients with gestational diabetes mellitus have impaired glucose metabolism when screened postpartum. These patients have a 40% to 70% lifetime risk of progression to type 2 diabetes mellitus, but progression can be delayed or prevented by lifestyle interventions or medication. The American College of Obstetricians and Gynecologists and the American Diabetes Association recommend a glucose tolerance test at 4 to 12 weeks postpartum for all patients with gestational diabetes mellitus. Despite these recommendations, postpartum screening rates are typically &lt;50%, representing a major healthcare “quality gap.” The Society for Maternal-Fetal Medicine proposes a uniform metric that identifies the percentage of persons with gestational diabetes mellitus who completed a 75-g, 2-hour glucose tolerance test within 12 weeks after delivery. The metric is designed to be measured using diagnosis and procedure codes in payor claims data. Barriers to screening are discussed. Possible uses of the metric for quality improvement projects are outlined. Increasing the rate of postpartum diabetes screening should facilitate timely referral to implement lifestyle modifications, medication, and long-term follow-up. Use of the metric in financial incentive programs is discouraged at this time.</description><subject>barriers</subject><subject>Blood Glucose - metabolism</subject><subject>cardiovascular disease</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes, Gestational - diagnosis</subject><subject>Female</subject><subject>fourth trimester</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>metabolic syndrome</subject><subject>obesity</subject><subject>Perinatology</subject><subject>Postpartum Period</subject><subject>Pregnancy</subject><subject>quality improvement</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9UU1vFCEYJsbGbqt_wIPh6GVGYBZmMF5MY9WkTdNsPRMWXrZsZmAEpk1_kX9TNlv15okAz9f7Pgi9paSlhIoP-1bv465lhLGWsraj_AVaUSL7RgxieIlWhBDWyK4fTtFZzvvDlUn2Cp12gg9rKegK_dpE46E8YRcTvtYFUtBjcwlFj_garDc-AN7MYHx92JQKmCCUj_h20aOvtAlK8gbHgMs94FT_cXR4jrnMOpVlwtbrLRTIOJsEEHzYYe2qDZ4T7IIO1T3jR1_u8Q5y1fexBvjHmmCsPkt-jU6cHjO8eT7P0Y_LL3cX35qrm6_fLz5fNabjojSOCEfX0NGeSGZsvzZgGeeWCcP41lnZsa2TljNOnO4NGRjtetvXdZgOQNLuHL0_6s4p_lxqIjX5bGoIHSAuWbGeSymY5KJC2RFqUsw5gVNz8pNOT4oSdShI7dWhIHUoSFGmakGV9O5Zf9lOYP9S_jRSAZ-OAKhTPnhIKtcVhTqHT2CKstH_T_83o_GlwA</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Bauer, Samuel T.</creator><creator>Cate, Jennifer J.M.</creator><creator>Whitsel, Amy I.</creator><creator>Combs, C. Andrew</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202304</creationdate><title>Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus</title><author>Bauer, Samuel T. ; Cate, Jennifer J.M. ; Whitsel, Amy I. ; Combs, C. Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>barriers</topic><topic>Blood Glucose - metabolism</topic><topic>cardiovascular disease</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes, Gestational - diagnosis</topic><topic>Female</topic><topic>fourth trimester</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>metabolic syndrome</topic><topic>obesity</topic><topic>Perinatology</topic><topic>Postpartum Period</topic><topic>Pregnancy</topic><topic>quality improvement</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bauer, Samuel T.</creatorcontrib><creatorcontrib>Cate, Jennifer J.M.</creatorcontrib><creatorcontrib>Whitsel, Amy I.</creatorcontrib><creatorcontrib>Combs, C. Andrew</creatorcontrib><creatorcontrib>Society for Maternal-Fetal Medicine (SMFM)</creatorcontrib><creatorcontrib>Patient Safety and Quality Committee</creatorcontrib><creatorcontrib>Patient Safety and Quality Committee. Electronic address: smfm@smfm.org</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bauer, Samuel T.</au><au>Cate, Jennifer J.M.</au><au>Whitsel, Amy I.</au><au>Combs, C. Andrew</au><aucorp>Society for Maternal-Fetal Medicine (SMFM)</aucorp><aucorp>Patient Safety and Quality Committee</aucorp><aucorp>Patient Safety and Quality Committee. Electronic address: smfm@smfm.org</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2023-04</date><risdate>2023</risdate><volume>228</volume><issue>4</issue><spage>B2</spage><epage>B9</epage><pages>B2-B9</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>As many as 1 in 3 patients with gestational diabetes mellitus have impaired glucose metabolism when screened postpartum. These patients have a 40% to 70% lifetime risk of progression to type 2 diabetes mellitus, but progression can be delayed or prevented by lifestyle interventions or medication. The American College of Obstetricians and Gynecologists and the American Diabetes Association recommend a glucose tolerance test at 4 to 12 weeks postpartum for all patients with gestational diabetes mellitus. Despite these recommendations, postpartum screening rates are typically &lt;50%, representing a major healthcare “quality gap.” The Society for Maternal-Fetal Medicine proposes a uniform metric that identifies the percentage of persons with gestational diabetes mellitus who completed a 75-g, 2-hour glucose tolerance test within 12 weeks after delivery. The metric is designed to be measured using diagnosis and procedure codes in payor claims data. Barriers to screening are discussed. Possible uses of the metric for quality improvement projects are outlined. Increasing the rate of postpartum diabetes screening should facilitate timely referral to implement lifestyle modifications, medication, and long-term follow-up. Use of the metric in financial incentive programs is discouraged at this time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36584961</pmid><doi>10.1016/j.ajog.2022.12.315</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2023-04, Vol.228 (4), p.B2-B9
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_2759962956
source Elsevier
subjects barriers
Blood Glucose - metabolism
cardiovascular disease
Diabetes Mellitus, Type 2 - diagnosis
Diabetes, Gestational - diagnosis
Female
fourth trimester
Glucose Tolerance Test
Humans
metabolic syndrome
obesity
Perinatology
Postpartum Period
Pregnancy
quality improvement
title Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A02%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Society%20for%20Maternal-Fetal%20Medicine%20Special%20Statement:%20Quality%20metric%20on%20the%20rate%20of%20postpartum%20diabetes%20screening%20after%20pregnancies%20with%20gestational%20diabetes%20mellitus&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Bauer,%20Samuel%20T.&rft.aucorp=Society%20for%20Maternal-Fetal%20Medicine%20(SMFM)&rft.date=2023-04&rft.volume=228&rft.issue=4&rft.spage=B2&rft.epage=B9&rft.pages=B2-B9&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2022.12.315&rft_dat=%3Cproquest_cross%3E2759962956%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-f06f14e317092cd74ced255d26c25bfd932bf9d5250fa7c082137d7658c3ee913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2759962956&rft_id=info:pmid/36584961&rfr_iscdi=true